Diabetes
Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Information is based on current medical literature and clinical guidelines but may not apply to your specific situation. Individual responses vary based on personal medical history and concurrent conditions. Always consult qualified healthcare providers for medical decisions. Never delay seeking medical care based on content you’ve read. If experiencing a medical emergency, seek immediate medical attention.
These articles provide education to enhance your healthcare partnership. All treatment decisions should involve your healthcare team. Use this knowledge to have informed discussions, not replace medical care.
In Brief: Hyperglycemia, Stress, and Cardiovascular Vulnerability
Many people with diabetes notice the same frustrating pattern during illness or after surgery: glucose rises sharply despite eating very little. The reason matters. The body has one unified stress response, and it raises glucose, induces insulin resistance, and shifts the cardiovascular system toward instability all at once. The medical complications that most often determine long-term clinical outcomes are rooted in the intersection of diabetes and heart disease. Understanding how does diabetes affect the heart is critical during acute illness, surgery, and pregnancy, as these are the exact periods when both glucose levels and cardiovascular stability are temporarily destabilized together. This article covers why these periods carry dual vulnerability, what to do during illness, what to plan before and after surgery, and why pregnancy operates as a lifelong cardiometabolic stress test. Most of the dangerous deterioration during these periods is reversible when caught early — which is why written plans, made before the stress arrives, do most of the work.
Glucose is what we measure — vascular injury is what determines outcomes.
Why the Acute Stress Response Destabilizes Diabetes and Heart Disease
Diabetes care is often framed around glucose. But as this series emphasizes, glucose is the measurable signal of a vascular disease. The chronic complications that drive long-term morbidity and mortality link diabetes and heart disease directly, precipitating clinical events such as myocardial infarction, stroke, and acute heart failure.¹
This becomes acutely relevant during physiologic stress — illness, surgery, and pregnancy. These periods do not merely worsen glycemic control. They activate the same hormonal, inflammatory, and prothrombotic pathways that directly precipitate cardiovascular events.²
The physiological stress response activates several concurrent survival mechanisms:
- It mobilizes large amounts of glucose into the bloodstream to provide immediate cellular fuel.
- It induces temporary insulin resistance to preserve circulating energy substrates.
- It elevates systemic blood pressure and accelerates clotting cascades to mitigate potential trauma.
- It triggers systemic inflammation, which provides acute utility but causes vascular harm when sustained.
The implication is concrete. A viral infection, a surgical procedure, or a complicated pregnancy does not just make glucose harder to control. It temporarily shifts the entire cardiovascular risk profile toward instability — while compromising the metabolic conditions that protect vascular health. Understanding this dual vulnerability explains why these periods demand specific attention.
An important reassurance. Most of the deterioration that occurs during these stress states is reversible when managed early. The body returns to baseline as the stress resolves. What matters is recognizing the window and acting within it — not avoiding the stress.
Can Stress Cause High Blood Sugar and Elevate Acute Vascular Risk?
The body does not distinguish between types of physiologic stress. A gastrointestinal virus triggers the exact same neuroendocrine diabetic stress response as a surgical incision. When patients inquire, “can stress cause high blood sugar?”, the answer lies in this precise counter-regulatory pathway that simultaneously affects metabolic and cardiovascular systems.
The Hormonal Cascade and Elevated Hepatic Glucose Output
Two pathways activate together during illness, surgery, or other physiologic stress²:
| Pathway | Hormones released | Metabolic effect | Cardiovascular effect |
| Sympathetic nervous system | Epinephrine, norepinephrine | Accelerates glycogenolysis; inhibits insulin secretion | Increased heart rate and blood pressure; increased platelet activation |
| Hypothalamic-pituitary-adrenal axis | Cortisol | Amplifies gluconeogenesis; breaks down muscle protein; induces insulin resistance | Promotes inflammation; affects vascular tone |
| Pancreatic islet | Glucagon ↑; insulin ↓ | Liver releases stored glucose | — |
The resulting state of acute stress hyperglycemia is often substantial, presenting even in the absence of nutritional intake. Under these conditions, accelerated hepatic glucose output continuously drives glucose into the circulation while peripheral tissues resist utilization. In people with diabetes, this compensation is inadequate.
How Diabetes Affects the Heart During Acute Hemodynamic Strain
The same hormones that raise glucose strain the cardiovascular system³:
- Increased heart rate and blood pressure
- Heightened platelet activation and clotting
- Inflammation affecting endothelial function
- Increased myocardial oxygen demand
- Potential plaque destabilization in coronary arteries
Acute hyperglycemia further impairs the endothelium’s nitric oxide signaling and increases platelet reactivity.⁴ In people with diabetes who already have accelerated atherosclerosis, these acute changes can precipitate cardiovascular events. The combination of hyperglycemia and the hemodynamic stress of illness or surgery creates a window of genuine cardiovascular vulnerability.
Why Stress Hyperglycemia Implies Worse Outcomes Even Without Diagnosed Diabetes
A modern observation worth knowing: in people without diabetes, hyperglycemia that appears during acute illness or after surgery is itself associated with worse outcomes — higher rates of infection, longer hospital stays, and higher mortality. The glucose elevation reveals a stress response severe enough to overwhelm normal compensation. It is a marker of physiologic strain, not just a number.³
Acute illness can also unmask previously unrecognized diabetes. A first abnormal glucose during a hospitalization is sometimes attributed to stress alone — but in a meaningful fraction of cases it represents underlying diabetes that was already present and undiagnosed. Follow-up testing after recovery (typically A1C plus repeat fasting glucose) clarifies which.
Differentiating Temporary Physiologic Stress from Chronic Insulin Resistance
Two different things share the name. The insulin resistance of acute stress, surgery, and pregnancy is temporary and reversible — it resolves as the stress resolves. The insulin resistance of Type 2 diabetes is progressive and chronic, developing over years and reflecting longer-term metabolic injury. Acute physiologic insulin resistance does not become Type 2 diabetes by itself. But repeated episodes — and the lifestyle factors often surrounding them — can contribute to the long-term trajectory in someone already predisposed.
Managing Acute Illness: Implementing Essential Diabetes Sick Day Rules
Acute illness — whether infection, gastrointestinal upset, or other physiologic stress — activates the stress response in its most recognizable form. For people with diabetes and cardiovascular disease, illness represents a period when both conditions can destabilize together.
Hepatic Glucose Output: Why Blood Sugar Rises Without Food Intake
A common and frustrating pattern: glucose climbs substantially despite minimal food intake. This seems paradoxical until you understand hepatic glucose output.⁵
The liver stores glycogen and rapidly elevates baseline hepatic glucose output during acute stress, completely independent of oral intake. This explains the physiological mechanism of how a systemic neuroendocrine surge can stress cause high blood sugar by instructing hepatic tissue to mobilize glycogen stores. In people with diabetes, the usual insulin response is inadequate to compensate. Glucose rises despite fasting.
This highlights the clinical rationale guiding basal insulin management during acute illness: in insulin-treated individuals, basal insulin coverage must generally continue even during strict fasting to suppress ongoing counter-regulatory ketogenesis. The body keeps producing glucose internally; it still needs insulin to use it.
Basal Insulin Management During Acute Illness to Oppose Ketogenesis
Insulin does several jobs that become critical during illness⁶:
- Preventing ketogenesis. Without adequate insulin, the body shifts to fat metabolism, producing ketones that can accumulate toward diabetic ketoacidosis.
- Preserving muscle. Cortisol breaks down muscle protein during stress; insulin opposes this catabolic effect. Inadequate insulin during illness contributes to the weakness and slow recovery many people experience after a hospitalization.
- Enabling glucose uptake. Despite high circulating glucose, cells cannot use it without insulin.
Not eating does not protect against DKA. The risk comes from insulin deficiency — not from food intake.
Recognizing Diabetic Ketoacidosis Protocols and Critical DKA Symptoms
DKA develops when insulin deficiency is severe enough to trigger unrestrained ketone production. It is often described as a metabolic emergency, but the cardiovascular implications are substantial⁷:
- Severe dehydration reduces cardiac output and coronary perfusion
- Electrolyte abnormalities (particularly potassium) create arrhythmia risk
- Acidosis impairs cardiac contractility
- The prothrombotic state increases risk of acute coronary events
Diabetic ketoacidosis represents a critical concern in Type 2 diabetes under several distinct clinical circumstances:
- During episodes of severe concurrent physiological illness or infection.
- In the presence of pancreatic insufficiency, such as after a pancreatectomy or in advanced chronic pancreatitis.
- During advanced beta-cell failure following many years of progressive Type 2 disease.
- Educational gaps labeling DKA solely as a Type 1 condition frequently delay clinical recognition and worsen patient outcomes.
Clinical care involving sglt2 inhibitors for type 2 diabetes necessitates strict caution during stress states. These specific sglt2 inhibitors can precipitate euglycemic dka sglt2 pathways during acute illness, manifesting as severe metabolic ketoacidosis despite normal or near-normal plasma glucose concentrations.⁸ The glucose-lowering effect of the drug masks the severity of insulin deficiency while ketones climb.⁸ People taking SGLT2 inhibitors should discuss ketone-testing strategies with their clinician and may be advised to check ketones when symptoms such as nausea, vomiting, or abdominal pain occur — even if glucose is not elevated.
Maintaining Proper Hydration Under Sick Day Rules Diabetes Type 1 and Type 2
Dehydration reduces kidney perfusion (worsening acute kidney injury risk) and concentrates the same stress hormones that are already elevated — amplifying both hyperglycemia and cardiovascular strain. Fluid intake during illness is more important than people realize, particularly with fever, vomiting, or diarrhea. When oral intake is not sustainable, evaluation for IV hydration is appropriate sooner rather than later.
Medication Holds: SGLT2 Inhibitors and Avoiding Euglycemic DKA
Several diabetes and cardiovascular medications require attention during illness with dehydration or vomiting. These adjustments should be discussed with the prescribing clinician before illness develops, and recorded in writing⁹:
| Medication | Concern during illness | Common approach |
| SGLT2 inhibitors | Euglycemic DKA risk | Hold during significant illness |
| Metformin | Lactic acidosis with dehydration or AKI | Hold; restart after kidney function confirmed |
| ACE inhibitors / ARBs | Worsen AKI during dehydration | Hold during significant dehydration |
| Diuretics | Compound dehydration | Hold during vomiting or diarrhea |
| NSAIDs | Reduce renal blood flow | Avoid during illness |
AKI = acute kidney injury.
These are temporary holds, not permanent stops. ACE inhibitors, ARBs, and SGLT2 inhibitors are cardiovascular- and kidney-protective in the long run; stopping them indefinitely because of one sick-day hold is a common error that erodes long-term protection. Restart should be coordinated with the clinical team once recovery is established.
When to Seek Urgent Medical Attention for Severe DKA Symptoms
When actively implementing diabetes sick day rules, particularly if executing specialized sick day rules diabetes type 1 protocols, certain clinical patterns warrant immediate emergency evaluation⁶:
- Ketones that are positive and rising on repeat checks, signaling definitive DKA symptoms
- Repeated vomiting or a complete inability to maintain oral fluid intake
- Signs of significant dehydration
- Confusion, severe weakness, or altered mental status
- Labored or rapid breathing
- Any symptoms suggesting cardiovascular instability: chest discomfort, severe shortness of breath, palpitations
Do not wait for glucose to be “very high” before asking for help. Ketones can rise while glucose is moderate (especially with SGLT2 inhibitors), and symptoms can progress faster than glucose readings suggest. For people with known coronary artery disease, the threshold for seeking evaluation should be lower — acute illness can destabilize previously stable angina or precipitate acute coronary syndromes.
Optimizing Continuous Glucose Monitoring (CGM) Calibration During Illness
For people who use CGM, the trend data become especially useful during illness — showing trajectory rather than isolated numbers. Frequent finger-stick confirmation may still be needed if dehydration or peripheral perfusion is poor, because sensor accuracy can degrade in those conditions.
Mitigating Diabetes Surgery Risk and Perioperative Stress
Surgery is a controlled physiologic stress, but it is trauma nonetheless. For individuals preparing for surgery with diabetes, particularly those with underlying macrovascular disease, the baseline diabetes surgery risk extends far beyond the immediate boundaries of the surgical wound.
Cardiovascular Vulnerability During Undergoing Surgery with Diabetes
Individuals undergoing major operative interventions exhibit a significantly heightened diabetes surgery risk regarding perioperative myocardial infarction and stroke.¹⁰
- Higher baseline prevalence of coronary artery disease, often more diffuse
- Autonomic dysfunction affecting heart rate and blood pressure regulation
- Impaired coronary flow reserve, limiting response to increased demand
- Several elements converge, including the prothrombotic and adverse endothelial effects of acute stress hyperglycemia.
The surgical stress response compounds these vulnerabilities. Even without infection, the tissue injury and inflammatory response of surgery itself raise insulin resistance and elevate stress hormones for days. The combination can precipitate demand-supply mismatch in vulnerable coronary territory or, less commonly, frank acute coronary events.
Preoperative Cardiovascular Assessment and Functional Capacity Reviews
Guidelines from the American College of Cardiology and American Heart Association recommend structured cardiovascular risk assessment before non-cardiac surgery.¹¹ For patients with diabetes, this often includes:
- Assessment of functional capacity (whether the person can perform activities equivalent to roughly four metabolic equivalents — climbing a flight of stairs, walking up a hill)
- Review of cardiovascular symptoms and stability
- ECG for intermediate- to high-risk procedures in patients with risk factors
- Additional testing (stress testing, echocardiography) when clinical assessment suggests it
Routine stress testing is not recommended for everyone before surgery. Testing is targeted by symptoms, functional capacity, and procedure risk — not applied universally. The goal of preoperative cardiovascular evaluation is not to “clear” patients for surgery but to identify conditions that might benefit from optimization, inform perioperative management, and guide honest discussions about surgical risk.
Clinical Protocols for Effective Perioperative Glucose Management
Both severe hyperglycemia and hypoglycemia are associated with worse outcomes during and after surgery.Hyperglycemia is associated with surgical site infections, delayed wound healing, and cardiovascular complications; hypoglycemia carries its own risks (neuroglycopenia, falls, arrhythmia). Consensus guidelines for standard perioperative glucose management recommend avoiding glycemic extremes in both directions, typically targeting a moderate inpatient range defined by institutional protocols rather than aggressive, strict normoglycemia.¹²
Surgical infection risk from hyperglycemia is real. Perioperative glucose elevations are independently associated with surgical site infection — both the depth of infection and the rate. This is particularly important in cardiac surgery, vascular surgery, and joint replacement, where deep infection has devastating consequences.
Managing Glucocorticoid-Induced Stress Hyperglycemia Variations
Glucocorticoids — prednisone, dexamethasone, methylprednisolone — are among the most powerful glucose-raising agents in medicine. They are commonly used perioperatively (for anti-inflammatory effects, for pain control, for some surgical pathways) and can raise glucose dramatically even in people without diabetes. In people with diabetes, the effect is often substantial enough to require insulin dose increases of 50–100% or more for the duration of steroid therapy.
Dexamethasone given as a single dose for postoperative nausea can produce 24–48 hours of significant hyperglycemia. Longer steroid courses (for asthma exacerbations, autoimmune disease, oncology protocols) require coordinated glucose management throughout the course. Anyone with diabetes prescribed steroids should expect a temporary regimen change and confirm the plan with the prescribing clinician.
Steroids raise glucose. The dose of insulin that controlled glucose yesterday will not control it the day prednisone starts.
Perioperative Medication Timing Rules for Glycemic Stability
| Medication | Common approach | Rationale |
| SGLT2 inhibitors | Stop 3+ days before surgery | Euglycemic DKA risk during surgical stress |
| Metformin | Hold 24–48 hours before | Lactic acidosis risk if AKI develops |
| GLP-1 agonists (daily) | Hold day before surgery | Aspiration risk from delayed gastric emptying |
| GLP-1 agonists (weekly) | Some anesthesia teams recommend holding 1 week before; guidance is evolving | Aspiration risk from delayed gastric emptying |
| Basal insulin | Generally continue (often reduced dose) | Prevents DKA; dose adjusted to fasting |
| Bolus insulin | Hold while NPO | No food = no mealtime bolus needed |
Follow your anesthesia team’s specific written instructions — they account for your procedure and individual risk factors.
Cardiovascular Medication Management Guidelines Prior to Surgery
Decisions about perioperative cardiovascular medications require individualized assessment¹¹:
Statins. Generally continued perioperatively. Evidence suggests benefit for reducing perioperative cardiovascular events, particularly in vascular surgery.
Beta-blockers. Continue if already taking chronically. Starting a beta-blocker specifically for perioperative risk reduction is more nuanced — the benefit-harm balance depends on clinical context and is generally reserved for higher-risk situations.
Antiplatelet agents. Decisions depend on the indication (primary versus secondary prevention), the time since coronary stent placement, the bleeding risk of the procedure, and the cardiovascular risk of interruption. Coordination between surgical and cardiology teams is essential — particularly for patients with recent stents, where premature discontinuation can cause stent thrombosis.
ACE inhibitors and ARBs. Often held the morning of surgery to reduce risk of intraoperative hypotension, though practice varies. Restart postoperatively when hemodynamically stable.
Postoperative Cardiovascular Monitoring to Address Diabetes Surgery Risk
The first few days after surgery represent a period of heightened cardiovascular risk. Myocardial injury is more common than the rate of clinical heart attacks alone would suggest — postoperative troponin elevation occurs frequently and is associated with adverse outcomes.¹³ Some of these elevations represent subclinical events that warrant follow-up evaluation rather than dismissal.
Warning signs that warrant evaluation:
- Chest discomfort or new shortness of breath
- Unexplained hypotension or tachycardia
- Glucose that was improving but suddenly worsens (often the first sign of developing infection or other complication)
- New arrhythmias
Cardiovascular events frequently present atypically during the early recovery period due to several overlapping factors:
- Postoperative pain medications can completely mask classic symptoms of angina.
- Significant intravascular fluid shifts and acute anemia from surgical blood loss increase baseline myocardial strain.
- The ongoing metabolic stress response alters standard clinical presentations, necessitating a lower diagnostic threshold for medical evaluation.
Hospital Transitions and Multi-Unit Perioperative Glucose Management
Glucose management errors are common at transitions — admission, transfer between units, transitions to outpatient care after discharge. Insulin orders may not transfer accurately; basal insulin may be inadvertently omitted; oral agents held for surgery may not be restarted at discharge; sick-day adjustments may persist beyond the situation that required them. Reviewing the diabetes regimen explicitly at every transition, and confirming home medication plans before discharge, reduces preventable post-discharge events.
Pregnancy, Gestational Diabetes Risks Factors, and Long-Term Heart Health
Pregnancy represents a unique physiologic stress state with implications that extend far beyond the gestational period. Evaluating the clinical overlay of preeclampsia and diabetes is vital, as this combination shifts maternal cardiovascular risks in both immediate and long-term ways.
How Gestational Adaptations Function as a Cardiovascular Stress Test
Normal pregnancy involves dramatic cardiovascular adaptations¹⁴:
- Blood volume increases by 40–50%
- Cardiac output rises significantly
- Heart rate increases
- Systemic vascular resistance decreases
These changes stress the cardiovascular system. Pregnancy can unmask previously silent metabolic and vascular vulnerability — pre-existing cardiovascular conditions may become symptomatic, latent cardiomyopathy may declare itself, and women with prior coronary artery disease face increased risk during pregnancy and delivery.
The metabolic changes are equally profound. Insulin sensitivity decreases substantially by the third trimester due to placental hormones — human placental lactogen, cortisol, and progesterone all contribute.¹⁵ This physiologic insulin resistance has a biological purpose: it helps ensure a steady glucose supply reaches the developing fetus. For women with pre-existing diabetes, insulin requirements may double during pregnancy. For women without pre-existing diabetes, this insulin resistance can unmask gestational diabetes.
Pregnancy functions as a physiologic stress test — and what it reveals can change cardiometabolic care for the next several decades.
Long Term Effects of Gestational Diabetes on Macrovascular Health
Identifying maternal gestational diabetes risks factors is critical, as the condition affects a substantial proportion of pregnancies. While glucose intolerance typically resolves after delivery, the long term effects of gestational diabetes represent a lifetime cardiovascular warning rather than a temporary metabolic inconvenience.¹⁶
Meta-analysis data indicate that women with a history of gestational diabetes have approximately sevenfold increased risk of developing Type 2 diabetes compared to women without gestational diabetes.¹⁷ And Type 2 diabetes, as this series emphasizes, substantially increases cardiovascular risk.
The cardiovascular signal extends beyond future diabetes. Even among women whose glucose returns to normal after delivery, long-term cardiovascular risk remains elevated¹⁸:
- Higher rates of cardiovascular disease in long-term follow-up
- Increased prevalence of metabolic syndrome
- Higher rates of hypertension and dyslipidemia
Gestational diabetes is not just a pregnancy complication. It is an early warning — a natural stress test that reveals underlying cardiometabolic vulnerability years before it would otherwise become apparent.
Women with a history of gestational diabetes warrant lifelong attention to cardiovascular risk factors, not just glucose screening.
Preeclampsia and Diabetes: Systems-Wide Endothelial and Vascular Risk
Clinical data confirms that preeclampsia and diabetes share an interconnected vascular pathophysiology; preeclampsia occurs more frequently in diabetic pregnancies, making the early recognition of preeclampsia symptoms paramount to limit systemic endothelial injury. It reflects systemic endothelial dysfunction: impaired vascular signaling, abnormal placental implantation, and inflammatory injury that affects every vascular bed in the body.¹⁹
The effects persist beyond pregnancy. Women with a history of preeclampsia have elevated long-term cardiovascular risk: hypertension, coronary artery disease, stroke, and heart failure all occur at higher rates. Like gestational diabetes, preeclampsia serves as an early indicator of cardiovascular vulnerability.
The combination of gestational diabetes and preeclampsia in the same pregnancy confers particularly elevated long-term cardiovascular risk and warrants aggressive attention to modifiable risk factors in the years following delivery.
Preconception Planning to Reduce Diabetes and Heart Disease Complications
For women with pre-existing diabetes planning pregnancy, preconception preparation substantially affects both pregnancy outcomes and cardiovascular health¹⁵:
Glucose optimization. Fetal organ development occurs in the first weeks of pregnancy — often before pregnancy is recognized. The relationship between preconception glucose control and risk of congenital malformations is well documented. Achieving target A1C before conception provides meaningful benefit.
Cardiovascular assessment. Women with long-standing diabetes should undergo evaluation for coronary artery disease before pregnancy. Pregnancy with significant underlying coronary disease carries substantial maternal risk that needs to be discussed openly.
Medication review. Several cardiovascular medications require discontinuation or substitution before conception. ACE inhibitors and ARBs are contraindicated during pregnancy; statins are generally stopped. Alternative blood pressure medications that are safer in pregnancy should be initiated before conception, not after.
Complication screening. Diabetic retinopathy can progress during pregnancy and is worth screening and stabilizing before conception. Diabetic nephropathy can also worsen during pregnancy; baseline kidney function assessment helps inform risk and monitoring.
Continuous Glucose Monitoring Integration and Gestational Diabetes Risks Factors
Continuous glucose monitoring has become especially useful during pregnancy, where tight glycemic targets and rapid physiologic changes make trend information clinically valuable. Many obstetric and diabetes teams now consider CGM standard for Type 1 diabetes in pregnancy and increasingly for Type 2 and gestational diabetes when intensive insulin therapy is required.
Postpartum Care Gaps: Tackling the Long Term Effects of Gestational Diabetes
The weeks and months after delivery represent a critical window that the healthcare system often fails to follow²⁰:
For women with gestational diabetes: Glucose testing at 4–12 weeks postpartum confirms that levels have returned to normal. Long-term screening — typically every 1–3 years — is recommended given the substantially elevated lifetime diabetes risk. In practice, this follow-up is often missed: women transition from intensive obstetric care to less frequent primary care, the gestational diabetes diagnosis may not transfer cleanly to the new clinician, and the urgency feels lower once the baby is delivered. Asking explicitly about follow-up screening at the first postpartum primary care visit is the most reliable way to ensure it happens.
For women with pre-existing diabetes: Postpartum metabolic shifts require immediate therapeutic modifications due to heightened risks of severe hypoglycemia:
- Insulin requirements drop precipitously immediately after delivery as placental hormones clear from the maternal circulation.
- Continuing third-trimester term insulin doses post-delivery can induce profound hypoglycemic episodes within days.
- Breastfeeding and the physiological energy demands of lactation further reduce required insulin quantities.
- Disrupted sleep patterns and irregular maternal meals complicate glycemic stability, necessitating a formal safety plan prior to hospital discharge.
For cardiovascular risk: Women with gestational diabetes, preeclampsia, or other pregnancy complications warrant ongoing cardiovascular risk surveillance. The Diabetes Prevention Program demonstrated that structured lifestyle intervention can reduce progression to Type 2 diabetes — a reminder that the cardiometabolic trajectory identified during pregnancy can be modified.
Practical Tools for Tracking Diabetes Sick Day Rules and Surgical Safety
Sick-Day Planning Guide: What Are the Rules for Diabetic Sick Days?
To establish comprehensive protocols for what are the rules for diabetic sick days, review these core elements with your healthcare team ahead of time to optimize basal insulin management during acute illness:
- At what glucose level should I check ketones to screen for developing DKA symptoms?
- What is my basal insulin adjustment plan when I cannot tolerate solid food?
- Which medications (diabetes and cardiovascular) should I hold during significant illness — and when should they be restarted?
- At what point should I contact you versus go to the emergency department?
- Should I have prescription antiemetics available at home?
- Do I have a current ketone meter and strips, and do I know how to use them?
Get written answers. When you are sick, you will not remember the conversation. These plans should be individualized and updated as medications change.
Pre-Surgical Discussion Guide for Undergoing Surgery with Diabetes
Discuss with your surgical and diabetes teams:
- Which medications should I stop, and when exactly?
- What is my cardiovascular risk, and does anything need optimization before surgery?
- Will I receive steroids during or after the procedure, and how will glucose be managed if so?
- Who is responsible for glucose management during the procedure?
- When do I restart my cardiovascular medications postoperatively?
- What signs should prompt me to seek evaluation after discharge?
Postpartum Follow-Up Checklist for Managing Gestational Diabetes Risks Factors
- Schedule glucose testing at 4–12 weeks postpartum before leaving the hospital
- Establish a primary care follow-up appointment and explicitly mention the gestational diabetes diagnosis at that visit
- Discuss long-term screening schedule (typically every 1–3 years)
- Maintain attention to cardiovascular risk factors: blood pressure, lipids, weight, activity
- Ask about breastfeeding support — lactation is associated with reduced long-term diabetes and cardiovascular risk
Clinical Bottom Line: Interconnected Risks of Diabetes and Heart Disease
The body has one stress response, and it affects glucose and the cardiovascular system simultaneously. Illness, surgery, and pregnancy activate hormonal cascades that raise glucose, induce insulin resistance, and shift the cardiovascular system toward instability. For people with diabetes, these are periods of dual vulnerability — metabolic and cardiovascular at once.
The practical implications are concrete. Basal insulin generally continues during illness; not eating does not protect against DKA. SGLT2 inhibitors require ketone vigilance during illness and pre-surgical hold. Steroids dramatically raise glucose and require regimen adjustment for the duration of treatment. Both severe hyperglycemia and hypoglycemia worsen perioperative outcomes; the goal is a moderate inpatient range, not aggressive normoglycemia. Cardiovascular medications need thoughtful perioperative planning — some continue, some hold temporarily, none should be permanently discontinued because of a single sick-day adjustment.
Gestational diabetes is a lifelong cardiovascular risk marker, not just a pregnancy complication. Preeclampsia carries similar long-term significance. The postpartum window, often lost to system gaps, is where these risks become either followed or forgotten.
These periods are temporary, but the physiologic stress is real. Preparation before illness, surgery, or pregnancy often determines how safely the body moves through them.
What Comes Next: Lifetime Tracking of the Diabetic Stress Response
Article 12 examines diabetes across the lifespan — how the disease, the body, and the goals of care change from adolescence through older adulthood, and what shifts at each stage.
Key Terms: Defining Stress Hyperglycemia, DKA Symptoms, and Euglycemic DKA
Stress response: The body’s coordinated hormonal response to physiologic threat, involving cortisol, catecholamines, glucagon, and inflammatory mediators that affect both glucose metabolism and cardiovascular function.
Stress hyperglycemia: Elevated glucose during acute illness or after surgery, occurring even in people without diabetes; an independent marker of worse outcomes.
Hepatic glucose output: Glucose released by the liver from glycogen stores (glycogenolysis) or made from non-carbohydrate sources (gluconeogenesis); the main reason glucose rises during illness without food.
Diabetic ketoacidosis (DKA): A dangerous complication of insulin deficiency characterized by high glucose, ketone accumulation, and metabolic acidosis. Can occur in both Type 1 and Type 2 diabetes.
Euglycemic DKA: DKA occurring with normal or near-normal glucose levels; particularly associated with SGLT2 inhibitor use during illness, fasting, or surgery.
Gestational diabetes: Glucose intolerance that develops during pregnancy and typically resolves after delivery, but signals increased lifetime risk of Type 2 diabetes and cardiovascular disease.
Preeclampsia: A pregnancy complication characterized by hypertension with proteinuria or end-organ dysfunction, representing systemic endothelial dysfunction with long-term cardiovascular implications.
Perioperative: The period surrounding surgery — preoperative preparation, the procedure itself, and early postoperative recovery.
Physiologic insulin resistance: The temporary, reversible insulin resistance produced by acute stress, surgery, or pregnancy; distinct from the progressive chronic insulin resistance of Type 2 diabetes.
Common abbreviations: DKA (diabetic ketoacidosis); SGLT2 (sodium-glucose cotransporter 2); GLP-1 (glucagon-like peptide 1); ACE (angiotensin-converting enzyme); ARB (angiotensin receptor blocker); NPO (nothing by mouth); AKI (acute kidney injury); MET (metabolic equivalent).
References
- Rawshani A, Rawshani A, Franzén S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379(7):633–644. https://doi.org/10.1056/NEJMoa1800256
- Desborough JP. The stress response to trauma and surgery. Br J Anaesth. 2000;85(1):109–117. https://doi.org/10.1093/bja/85.1.109
- Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373(9677):1798–1807. https://doi.org/10.1016/S0140-6736(09)60553-5
- Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JC, Hoekstra JB. Hyperglycemia: a prothrombotic factor? J Thromb Haemost. 2010;8(8):1663–1669. https://doi.org/10.1111/j.1538-7836.2010.03910.x
- Cryer PE. Glucose counterregulation: prevention and correction of hypoglycemia in humans. Am J Physiol. 1993;264(2 Pt 1):E149–E155. https://doi.org/10.1152/ajpendo.1993.264.2.E149
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes — 2024. Diabetes Care. 2024;47(Suppl 1):S1–S321. https://doi.org/10.2337/dc24-Sint
- Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335–1343. https://doi.org/10.2337/dc09-9032
- Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015;38(9):1687–1693. https://doi.org/10.2337/dc15-0843
- Dhatariya K, Levy N, Kilvert A, et al. NHS Diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med. 2012;29(4):420–433. https://doi.org/10.1111/j.1464-5491.2012.03582.x
- Halkos ME, Puskas JD, Lattouf OM, et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2008;136(3):631–640. https://doi.org/10.1016/j.jtcvs.2008.02.091
- Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. J Am Coll Cardiol. 2014;64(22):e77–e137. https://doi.org/10.1016/j.jacc.2014.07.944
- Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–1131. https://doi.org/10.2337/dc09-9029
- Devereaux PJ, Biccard BM, Sigamani A, et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2017;317(16):1642–1651. https://doi.org/10.1001/jama.2017.4360
- Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014;130(13):1003–1008. https://doi.org/10.1161/CIRCULATIONAHA.114.009029
- American Diabetes Association Professional Practice Committee. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes — 2024. Diabetes Care. 2024;47(Suppl 1):S282–S294. https://doi.org/10.2337/dc24-S015
- Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–2486. https://doi.org/10.1056/NEJMoa042973
- Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–1779. https://doi.org/10.1016/S0140-6736(09)60731-5
- Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019;62(6):905–914. https://doi.org/10.1007/s00125-019-4840-2
- Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348:g2301. https://doi.org/10.1136/bmj.g2301
- Gunderson EP, Hurston SR, Ning X, et al. Lactation and progression to type 2 diabetes mellitus after gestational diabetes mellitus. Ann Intern Med. 2015;163(12):889–898. https://doi.org/10.7326/M15-0807
HeartBuddi • Your heart. Own it.